Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles
HK$214 million, 163% gain: What scale of capital story is KPA-BM HLDGS (02663) trying to tell?
Guosen: Semiconductor Manufacturing International Corporation (00981) 3Q26 revenue and gross margin both exceeded the upper end of guidance; maintain "Outperform" rating.
CITIC SEC: Structural turning points in the market are increasing in 2027; K-shaped convergence and broader market breadth may be the most important features.
HK$214 million, 163% gain: What scale of capital story is KPA-BM HLDGS (02663) trying to tell?
Guosen: Semiconductor Manufacturing International Corporation (00981) 3Q26 revenue and gross margin both exceeded the upper end of guidance; maintain "Outperform" rating.
CITIC SEC: Structural turning points in the market are increasing in 2027; K-shaped convergence and broader market breadth may be the most important features.
